Total submissions: 18
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081801 | SCV000113736 | benign | not specified | 2013-07-24 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000081801 | SCV000152347 | benign | not specified | 2015-08-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000081801 | SCV000196863 | benign | not specified | 2016-11-04 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000081801 | SCV000307101 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Athena Diagnostics | RCV000710195 | SCV000614740 | likely benign | not provided | 2020-04-08 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001082774 | SCV000649960 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2O; Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000671438 | SCV000796414 | likely benign | Muscle eye brain disease | 2017-12-13 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000671438 | SCV001135280 | likely benign | Muscle eye brain disease | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000004204 | SCV001254092 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2O | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001097781 | SCV001254093 | uncertain significance | Congenital Muscular Dystrophy, alpha-dystroglycan related | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Genome- |
RCV001449938 | SCV001653392 | uncertain significance | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 | 2021-05-18 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001579237 | SCV001806695 | likely benign | Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3 | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000004204 | SCV001806696 | likely benign | Autosomal recessive limb-girdle muscular dystrophy type 2O | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001579238 | SCV001806697 | likely benign | Retinitis pigmentosa 76 | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000081801 | SCV002050986 | likely benign | not specified | 2021-12-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000710195 | SCV002821397 | benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | POMGNT1: BS1, BS2 |
OMIM | RCV000004204 | SCV000024370 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2O | 2008-11-01 | no assertion criteria provided | literature only | |
Natera, |
RCV000671438 | SCV001464157 | benign | Muscle eye brain disease | 2020-01-06 | no assertion criteria provided | clinical testing |